Table 1.
Cell viability of human adipose-derived stem cells (hASCs) after 24 h cytochalasin B (CB) treatment and after a 24 or 48 h recovery time.
| Group |
t of Analysis 24 h |
t of Analysis 24 h + 24 h |
t of Analysis 4 h + 48 h |
|---|---|---|---|
| CTR | 99.4 ± 1.5 | 97.8 ± 1.9 | 97.9 ± 2.1 |
| DMSO | 99.0 ± 2.4 | 96.1 ± 4.0 | 97.1 ± 2.7 |
| CB 0.1 µM | 100.0 ± 0.0 | 96.7 ± 2.8 | 97.0 ± 3.1 |
| CB 1 µM | 96.1 ± 4.9 | 98.4 ± 1.8 | 96.9 ± 2.8 |
| CB 10 µM | 89.1 ± 7.0 | 93.9 ± 5.8 | 94.1 ± 4.1 |
t: time; 24 h: after 24 h of treatment; 24 h + 24 h: 24 h after chemical wash-out; 24 h + 48 h: 48 h after chemical wash-out; CB: cytochalasin-B-treated cells; DMSO: dimethyl sulfoxide-treated cells; CTR: control (untreated cells). Cell viability: percentage of living cells/total number of cells ± standard deviation (SD).